Skip to content

MR Characterisation/Localisation of Breast Cancer

Using Magnetic Resonance Techniques to Improve the Characterisation and Localisation of Breast Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01567137
Enrollment
16
Registered
2012-03-30
Start date
2007-11-30
Completion date
2011-11-30
Last updated
2016-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

Objective: To determine the accuracy of multi-functional magnetic resonance (MR) in detecting, localising and characterising satellite lesions in relation to an index breast tumour in order to improve definition of clinical target volume after local excision. Hypothesis: Pre-operative multi-functional MR has high sensitivity and specificity for localising unsuspected multifocal and multicentric lesions in women diagnosed with early breast cancer.

Interventions

None listed

Sponsors

Institute of Cancer Research, United Kingdom
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Biopsy proven invasive ductal carcinoma of the breast * Unifocal disease * Patient proceeding to mastectomy

Exclusion criteria

* Multifocal disease * Previous surgery to ipsilateral breast * Neoadjuvant chemotherapy * Ferromagnetic implants * Claustrophobia * Cup size DD or greater

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of MR techniques in detecting histopathologically-identified multifocal and multicentric lesions4 yearsSensitivity of the MR technique in detecting histopathologically-identified multifocal/centric pre-invasive/invasive disease will be calculated (with 95% confidence intervals)from positive or negative correlates.

Secondary

MeasureTime frameDescription
Closeness of agreement between MR techniques and histopathology in localising satellite lesions relative to the index tumour.4 yearsDistance & distribution of lesions from reference tumour will be plotted and correlated with distances and signal characteristics seen on multifunctional MR. Pre-op MRI volume will be plotted against histopathological dimensions and examined for agreement between the two methods. Paired Wilcoxon signed-rank tests will be used to test for systematic differences between MRI and pathology measurements.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026